Cell-Free DNA Testing for Solid Tumours in Canada
Date: May 27th, 12pm – 1:30pm. EST
Speakers:

Alan Spatz
Director, Department of Pathology, Jewish General Hospital
Professor, Departments of Pathology, and Oncology, McGill University

Tracy Stockley PhD, FCCMG, FACMG
Scheme Director, Canadian Biomarker Quality Assurance
Professor, Department of Laboratory Medicine & Pathobiology
University Health Network, Toronto
Stockley is a molecular geneticist and Director of Hereditary Genomics in the Genome Diagnostics Division at University Health Network in Toronto. At UHN, Dr. Stockley participates in overseeing genetic testing for oncology, including hereditary cancer, companion diagnostics and the development of genomic tests for emerging biomarkers. Dr. Stockley has research and clinical interests in improving quality assurance in high-complexity laboratory testing, and engages in quality activities with multiple national and international organizations, including Health Canada, the Canadian Biomarker Quality Assurance program, the College of American Pathologists, Association for Molecular Pathology, the European Molecular Quality Network and the International Organization for Standardization (ISO). In addition, Dr. Stockley is a Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto, and is a past President of the Canadian College of Medical Geneticists (CCMG). Dr. Stockley is also a cancer survivor with a personal interest in patient support and engagement in research.

Tracy Tucker PhD, FCCMG
Vancouver, British Columbia
Clinical Professor, University of British Columbia
Clinical Molecular Geneticist & Cytogeneticist, Cancer Genetics Laboratory, BC Cancer Agency
Dr. Tracy Tucker is a CCMG certified Cytogeneticist and Molecular Geneticist at the Cancer Genetic and Genomics Laboratory (CGL) at the BC Cancer Centre and is a Clinical Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (UBC). She received her PhD in Medical Genetics at UBC followed by clinical genetics fellowship training and Canadian College of Medical Geneticists (CCMG) certification at BC Children’s and Women’s Hospitals. In her clinical role, Dr. Tucker is focused on the identification of acquired and inherited genetic changes to diagnose cancer patients and help direct their care. She has a keen interest in transitioning high throughput technologist into the clinical laboratory for routine cancer care. Dr. Tucker has educational leadership roles, both locally and nationally, to enhance genetics training for pathology residents, undergraduate students, CCMG fellows and practicing pathologists. She is a recipient of a UBC Killam Teaching Award.
Learning Objectives:
After this session, the participants will be able to:
- Review the methods and approaches for testing of cell free DNA using NGS
- Describe the results of the international IQNPath proficiency testing scheme using cell free DNA testing for solid tumors
- Recognize the challenges and opportunities for integration of cell free DNA testing into current laboratory testing in Canadian labs